Search results
Results from the WOW.Com Content Network
Experimental cancer treatments are normally available only to people who participate in formal research programs, which are called clinical trials. Occasionally, a seriously ill person may be able to access an experimental drug through an expanded access program. Some of the treatments have regulatory approval for treating other conditions.
AOH1996 is an experimental anticancer medication which acts as a small molecule inhibitor of proliferating cell nuclear antigen (PCNA) and is in Phase I clinical trials at City of Hope as of August 2023 for the treatment of solid tumors. [1] [2] [3] [4]
Experimental cancer drugs (262 P) D. ... Experimental drugs developed for non-alcoholic fatty liver disease (1 C, 24 P) Experimental drugs for Alzheimer's disease ...
A new treatment for liver cancer which isolates the organ and “bathes” it in chemotherapy has been found to be effective in almost 90% of patients. ... Once the drug has been delivered, blood ...
The effects were observed in fatty livers, suggesting that rencofilstat may increase the treatment potential of anti-PD1 treatment in human liver cancer. Drug treatments began on Day 14 after HCC ...
It is developed by Galecto Biotech, which is testing the molecule to see if it reduces decompensated cirrhosis [2] and resistance to checkpoint inhibitors (a type of anti-cancer drug). [ 3 ] [ 4 ] References
The new study found that between 2013 and 2017, there were 46 cancer drugs granted accelerated approval. Of those, 63% were converted to regular approval even though only 43% demonstrated a ...
Pages in category "Experimental cancer drugs" The following 200 pages are in this category, out of approximately 262 total. This list may not reflect recent changes.